Abstract
AbstractWhile both production function (PF) and Absorptive Capacity (AC) explanations have played an important role in explaining the relationship between a firm's Research and Development (R&D) and its innovation, each has developed independently of the contributions of the other. The purpose of this study is to theoretically and empirically develop a concept of AC that incorporates the role of diminishing returns and external spillovers (i.e., strategic alliances) into a biotechnology firm's R&D‐innovation process. In using count estimations, this study finds that a firm's R&D‐innovation process is subject to a nonlinear ‐U‐shaped‐ learning process and that this process is moderated by its strategic partnerships. The contribution of this study is that it challenges the linearity assumptions and findings of AC research and that it offers a greater openness to PF explanations of the R&D‐innovation process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
